X

Trial Profile

A Blind, Randomized and Controlled Clinical Trial to Evaluate the Safety of Live Attenuated Varicella Vaccines for Healthy Adults, Adolescents and Children

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 17 Sep 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Varicella zoster virus vaccine Sinovac (Dalian) Vaccine Technology (Primary)
Indications Varicella zoster virus infections
Focus Adverse reactions
Sponsors Sinovac Biotech

Most Recent Events

19 Oct 2016 According to a Sinovac Biotech media release, status changed from active, no longer recruiting to completed.
26 May 2016 Status changed from not yet recruiting to recruiting, as reported in a Sinovac Biotech media release.
05 Apr 2016 According to a Sinovac Biotech media release, the clinical trials of varicella vaccine are expected to be launched in the first half of 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com